2 results
Approved WMORecruiting
This is an open-label, non-randomized, multicentre phase II study with an initial safety-run in. During the safety run-in phase, we will investigate the safety of combining IMM-101 administration with SBRT in 20 patients with limited metastatic…
Approved WMORecruiting
This study investigates the correlation between IOS and the severity of fibrosis on HRCT in patients with IPF. It also investigates which IOS parameter best relates to the degree of fibrosis on the HRCT. Furthermore, as a secondary endpoint, it is…